Published in Medical Letter on the CDC and FDA, October 28th, 2007
"Several decades-long search for alternative forms of insulin delivery has finally resulted in the USA. Food and Drug Administration's approval of the first inhaled insulin delivery system, Exubera. Inhaled insulin provides hope that minimizing barriers to initiating insulin therapy will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.